These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9070487)
21. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111 [TBL] [Abstract][Full Text] [Related]
23. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells. Lebedeva IV; Su ZZ; Emdad L; Kolomeyer A; Sarkar D; Kitada S; Waxman S; Reed JC; Fisher PB Oncogene; 2007 Feb; 26(5):733-44. PubMed ID: 16924242 [TBL] [Abstract][Full Text] [Related]
24. Frequent p53 gene mutations in serrated adenomas of the colorectum. Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427 [TBL] [Abstract][Full Text] [Related]
25. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999 [TBL] [Abstract][Full Text] [Related]
26. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Conzelmann M; Linnemann U; Berger MR Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598 [TBL] [Abstract][Full Text] [Related]
27. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
28. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507 [TBL] [Abstract][Full Text] [Related]
29. Low expression of bcl-2 in Brca1-associated breast cancers. Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356 [TBL] [Abstract][Full Text] [Related]
30. Colorectal carcinoma with special reference to growth pattern classifications: clinicopathologic characteristics and genetic changes. Kurahashi T; Kaneko K; Makino R; Mitamura K J Gastroenterol; 2002; 37(5):354-62. PubMed ID: 12051534 [TBL] [Abstract][Full Text] [Related]
31. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression. De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895 [TBL] [Abstract][Full Text] [Related]
32. Change of apoptotic status in the human colorectal adenoma-carcinoma sequences and its correlation with carcinogenesis and prognosis. Li L; Yan L; Wang Z; Liu Z; Wei Y; Huang G Chin Med J (Engl); 2000 Oct; 113(10):886-8. PubMed ID: 11775833 [TBL] [Abstract][Full Text] [Related]
33. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability. Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084 [TBL] [Abstract][Full Text] [Related]
34. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Jones S; Lambert S; Williams GT; Best JM; Sampson JR; Cheadle JP Br J Cancer; 2004 Apr; 90(8):1591-3. PubMed ID: 15083190 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194 [TBL] [Abstract][Full Text] [Related]
36. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247 [TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493 [TBL] [Abstract][Full Text] [Related]
38. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951 [TBL] [Abstract][Full Text] [Related]
39. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation. Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880 [TBL] [Abstract][Full Text] [Related]
40. Adenoma-carcinoma sequence of colorectum. Prevalence of K-ras gene mutation in adenomas with increasing degree of dysplasia and aneuploidy. Ranaldi R; Gioacchini AM; Manzin A; Clementi M; Paolucci S; Bearzi I Diagn Mol Pathol; 1995 Sep; 4(3):198-202. PubMed ID: 7493139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]